Postoperative Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Postoperative Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-10-29FDA Approved: PALONOSETRON HYDROCHLORIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for palonosetron hydrochloride from Sandoz Inc, authorizing changes under the ANDA pathway.
-
FDA approval · 2019-09-25FDA Approved: EMEND — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for EMEND (aprepitant) by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2019-08-19Clinical Trial Update: Post-Operative Nausea and Vomiting in Children Submitted to Strabismus Surgery [Phase 3]
Phase 3 clinical trial evaluating postoperative nausea and vomiting in children undergoing strabismus surgery.
-
CLINICAL_TRIALS trial_result · 2019-08-02Clinical Trial Update: European Phase III Study of APD421 in PONV [Phase 3]
Phase III trial of APD421 in postoperative nausea and vomiting has completed with results posted.
-
FDA approval · 2019-07-16FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for metoclopramide, a generic, indicating an updated or additional labeling under an approved A…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: Opioid Free Versus Opioid Balanced Anesthesia [Phase 4]
Phase 4 trial comparing opioid-free versus opioid-balanced anesthesia; completed study focusing on postoperative nausea and vomiting and opi…
-
FDA approval · 2019-06-19FDA Approved: SCOPOLAMINE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved Mylan's original Abbreviated New Drug Application for scopolamine, enabling a generic version of the product.
-
CLINICAL_TRIALS trial_result · 2019-05-28Clinical Trial Update: A Study to Compare Neostigmine vs Sugammadex in Length of PACU Stay in Patients Undergoing Sleeve Gastrectomy Surgery [Phase 4]
A Phase 4 clinical trial comparing neostigmine with sugammadex for reducing length of stay in the PACU after sleeve gastrectomy; the study i…
-
FDA approval · 2019-05-24FDA Approved: METOCLOPRAMIDE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for metoclopramide hydrochloride, authorizing an updated approval for this …
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Granisetron Transdermal Patch for Prevention of Postoperative Nausea and Vomiting [Phase 2]
Phase 2 trial update for a granisetron transdermal patch aiming to prevent postoperative nausea and vomiting has been completed with results…
-
CLINICAL_TRIALS trial_result · 2019-03-12Clinical Trial Update: PALONOSETRON X FOSAPREPITANT IN PONV [Phase 4]
Phase 4 trial update involving palonosetron and fosaprepitant for postoperative nausea and vomiting (PONV).
-
CLINICAL_TRIALS trial_result · 2019-03-07Clinical Trial Update: Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis [NA]
Clinical trial update documenting real-time decision support for prophylaxis of postoperative nausea and vomiting; study status completed wi…
-
FDA approval · 2019-03-01FDA Approved: TRANSDERM SCOP — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved a supplemental application for Transderm Scop (scopolamine) by Baxter Healthcare Corporation, updating the product's approv…
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: Effects of Two Packing Type in Maxillofacial Surgery [Phase 4]
Phase 4 clinical trial completed comparing two packing types in maxillofacial surgery, monitoring postoperative sore throat and postoperativ…
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Therapeutic Efficacy of Ramosetron for Treatment of Established PONV After Laparoscopic Surgery [NA]
Clinical trial update reports on Ramosetron's therapeutic efficacy for established postoperative nausea and vomiting after laparoscopic surg…
-
CLINICAL_TRIALS trial_result · 2019-01-29Clinical Trial Update: Effect of Using Azithromycin Versus Placebo With Dexamethasone in Prevention of Post-spinal Nausea and Vomiting. [Phase 4]
Phase 4 clinical trial assessing whether adding azithromycin to dexamethasone reduces post-spinal postoperative nausea and vomiting compared…
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: Guanfacine for PONV and Pain After Sinus Surgery [NA]
Clinical trial update for guanfacine in postoperative nausea, vomiting, and pain after sinus surgery; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Study of APD421 as PONV Treatment (no Prior Prophylaxis) [Phase 3]
Phase 3 clinical trial results for APD421 as a treatment for postoperative nausea and vomiting have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Study of APD421 as PONV Treatment (Prior Prophylaxis) [Phase 3]
Phase 3 study of APD421 for preventing postoperative nausea and vomiting has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2018-12-05Clinical Trial Update: Effect of Pulmonary Recruitment Maneuver (PRM) on Pain and Nausea After Laparoscopic Bariatric Surgery [NA]
Clinical trial evaluating the effect of pulmonary recruitment maneuvers on postoperative pain and nausea after laparoscopic bariatric surger…
-
FDA approval · 2018-11-06FDA Approved: PALONOSETRON HYDROCHLORIDE — Original Application (Eugia US LLC)
The FDA approved Eugia US LLC's original application for palonosetron hydrochloride (generic) to prevent chemotherapy- and postoperative-ind…
-
CLINICAL_TRIALS trial_result · 2018-11-01Clinical Trial Update: TIVA Versus Desfluran Anaesthesia in Patients Undergoing Bariatric Surgery [Phase 2]
A Phase 2 trial comparing total intravenous anesthesia (TIVA) to desflurane anesthesia in bariatric surgery has completed.
-
FDA approval · 2018-10-25FDA Approved: PROCHLORPERAZINE EDISYLATE — Original Application (Mylan Institutional LLC)
The FDA approved the original ANDA for Prochlorperazine Edisylate by Mylan Institutional LLC, enabling a generic version of this antiemetic.…
-
CLINICAL_TRIALS trial_result · 2018-09-20Clinical Trial Update: Study of the Effect of the Drug Gabapentin on Postoperative Pain and Incidence of Postoperative Nausea and Vomiting [NA]
Clinical trial update on gabapentin for postoperative pain and nausea/vomiting in morbid obesity; study completed with results posted.
-
FDA approval · 2018-09-19FDA Approved: PALONOSETRON — Original Application (Fresenius Kabi USA, LLC)
FDA approved Fresenius Kabi USA, LLC's original application for Palonosetron, a generic antiemetic, for the prevention of chemotherapy- and …